Medicare, Medicaid & Chip

Medicare and Medicaid Regulatory Comment Letters

• ACEP Comments on the 2020 Medicare Part C and D Advance Notice and Draft Call Letter - February 28, 2019
• ACEP Summary of CMS and ONC Proposed Rule on Health IT - February 20, 2019
• ACEP Comments on HHS' RFI on HIPAA Revisions - February 12, 2019
• ACEP Comments on Office of the National Coordinator for Health IT's Burden Reduction Draft Strategy - January 25, 2019
• ACEP Comments on CMS' Proposal on Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses - January 24, 2019
• Summary of 2019 Medicare Shared Savings/ACO Program Final Rule
• ACEP Response to Medicaid Managed Care Proposed Rule - January 10, 2019
• ACEP Comments on IPI Drug Pricing Model - December 27, 2018
• ACEP Comments on State Relief and Empowerment (i.e. Section 1332) Waivers - December 21, 2018
• Summary of 2019 Medicare Physician Fee Schedule and MACRA/QPP Final Rule - November 5, 2018
• ACEP Comments on Proposed Rule on Medicare ACO Program - October 16, 2018
• ACEP Comments on CY 2019 OPPS Proposed Rule - September 24, 2018
• Summary of Emergency Medicine-related Provisions in CMS Proposed Rule on Reducing Provider Regulatory Burdens - September 17, 2018
• Summary of ACEP Comment Letter on 2019 Medicare PFS and MACRA/QPP Proposed Rule - September 10, 2018
  • Full ACEP Comment Letter
  • Summary of CMS Proposed Rule
• ACEP Comments on CY 2019 Medicare Inpatient Prospective Payment System (IPPS) Proposed Rule - June 22, 2018
• ACEP Comments on the Exemptions to Methods for Assuring Access to Covered Medicaid Services Proposed Rule - May 22, 2018
• ACEP Comments on the 2019 Medicare Part C and D Advance Notice and Draft Call Letter - March 5, 2018
• ACEP Comments on 2019 Medicare Advantage and Part D Proposed Rule - January 16, 2018